Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-11,380
Closed -$927K 403
2024
Q3
$927K Buy
11,380
+2,683
+31% +$215K 0.05% 374
2024
Q2
$646K Buy
8,697
+815
+10% +$61.1K 0.04% 431
2024
Q1
$614K Buy
7,882
+253
+3% +$18.8K 0.05% 415
2023
Q4
$545K Buy
7,629
+1,043
+16% +$72.6K 0.05% 423
2023
Q3
$457K Sell
6,586
-1
-0% -$76 0.05% 419
2023
Q2
$533K Sell
6,587
-223
-3% -$18.2K 0.06% 395
2023
Q1
$550K Buy
6,810
+58
+0.9% +$4.67K 0.07% 373
2022
Q4
$505K Buy
6,752
+260
+4% +$18.5K 0.07% 380
2022
Q3
$419K Buy
6,492
+699
+12% +$48.4K 0.06% 387
2022
Q2
$401K Buy
5,793
+1,958
+51% +$145K 0.06% 396
2022
Q1
$295K Buy
3,835
+484
+14% +$34.8K 0.04% 510
2021
Q4
$257K Sell
3,351
-10
-0.3% -$735 0.03% 538
2021
Q3
$248K Buy
+3,361
New +$252K 0.04% 537
2021
Q1
Sell
-443
Closed -$32K 652
2020
Q4
$32K Buy
+443
New +$31.3K 0.01% 830

Other funds holding HOLX

First Trust Direct Indexing's HOLX Position: Q4 2024 in Review

First Trust Direct Indexing sold out of Hologic (HOLX) in Q4 2024, closing a stake of 11,380 shares — an estimated $927K sold.

First Trust Direct Indexing first reported a position in HOLX in Q4 2020 and held it in 14 quarters. The position peaked at $927K in Q3 2024. 718 funds tracked by Wall St. Rank hold HOLX as of Q4 2024.

  • First Trust Direct Indexing reported no remaining Hologic position as of Q4 2024 after selling out during the quarter.
  • First Trust Direct Indexing sold 11,380 Hologic shares in Q4 2024, an estimated $927K.
  • First Trust Direct Indexing first reported a position in Hologic in Q4 2020 and held it in 14 quarters.
  • First Trust Direct Indexing's Hologic position peaked at $927K in Q3 2024.
  • 718 funds tracked by Wall St. Rank held Hologic as of Q4 2024.

Based on First Trust Direct Indexing's 13F filing for Q4 2024.